Literature DB >> 9768636

Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.

J M Heward1, A Allahabadia, J Daykin, J Carr-Smith, A Daly, M Armitage, P M Dodson, M C Sheppard, A H Barnett, J A Franklyn, S C Gough.   

Abstract

Early case control studies found association of the DRB1 allele, DR3, with Graves' disease (GD). Recent reports, claim the DQA1 allele, DQA1*0501, to be the primary susceptibility determinant within the human leukocyte antigen (HLA) class II region. We typed 228 GD patients, 364 controls, and 98 families (parents, GD, and unaffected sibling) at the DRB1, DQB1, and DQA1 loci. The case control study showed an increased frequency in GD, compared to controls, of DRB1*0304 (47% vs. 24%; pc < 1.4 x 10(-5)), DQB1*02 (58% vs. 46%; pc < 0.035), DQB1*0301/4 (42% vs. 28%; pc < 3.5 x 10(-3)) and DQA1*0501 (67%, vs. 39%; pc < 7 x 10(-6)). The DRB1*0304-DQB1*02-DQA1*0501 haplotype was increased in GD (47%) vs. controls (24%; pc < 1.8 x 10(-5); odds ratio = 2.72). No independent association of these alleles was observed. Preferential transmission of DRB1*0304-DQB1*02-DQA1*0501 from parents heterozygous for the haplotype to GD siblings (72%) was seen in the families (chi2 = 11.95; 1 d.f.; P = 0.0005). Lack of preferential transmission to unaffected siblings (53%; chi2 = 0.19; 1 d.f.; P = NS) excluded segregation distortion. These results show that linkage disequilibrium between GD and the HLA class II region is due to the extended haplotype DRB1*0304-DQB1*02-DQA1*0501.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768636     DOI: 10.1210/jcem.83.10.5137

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

1.  HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease.

Authors:  G Philippou; A Krimitzas; G Kaltsas; E Anastasiou; A Souvatzoglou; M Alevizaki
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

Review 2.  Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.

Authors:  Akane Ide; George S Eisenbarth
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

3.  Graves' disease and gene polymorphism of TNF-α, IL-2, IL-6, IL-12, and IFN-γ.

Authors:  Mehdi Anvari; Omid Khalilzadeh; Alireza Esteghamati; Fatemeh Momen-Heravi; Mahdi Mahmoudi; Shadi Abdar Esfahani; Armin Rashidi; Aliakbar Amirzargar
Journal:  Endocrine       Date:  2010-03-05       Impact factor: 3.633

4.  Evaluation of hearing loss in patients with Graves' disease.

Authors:  Dilek Berker; Hayriye Karabulut; Serhat Isik; Yasemin Tutuncu; Ufuk Ozuguz; Gonul Erden; Yusuf Aydin; Muharrem Dagli; Serdar Guler
Journal:  Endocrine       Date:  2011-08-11       Impact factor: 3.633

5.  Genetic associations of FCRL3 polymorphisms with the susceptibility of Graves ophthalmopathy in a Chinese population.

Authors:  Shanshan Wu; Ting Cai; Feng Chen; Xuefei He; Zhihua Cui
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Association of the TGrI29 microsatellite in thyroglobulin gene with autoimmune thyroiditis in a Argentinian population: a case-control study.

Authors:  Viviana Varela; Leonardo Rizzo; Sabina Domené; Oscar D Bruno; Mariana L Tellechea; Carina M Rivolta; Héctor M Targovnik
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 8.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

Review 9.  Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure?

Authors:  Fabrizio Gentile; Marisa Conte; Silvestro Formisano
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

Review 10.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.